申请人:Abbott Laboratories
公开号:US05120751A1
公开(公告)日:1992-06-09
Benzoylphenyl derivatives of 2-(3-pyridinyl)-3-alkyl-4-thiazolidinecarboxamide, 2-(3-pyridinyl)-thiazolid-4-ylacetamide, 2-(3-pyridinyl)-4-dithiolanecarboxamide or 2-(3-pyridinyl)dithiolan-4-yl] urea are potent inhibitors of PAF and are useful in the treatment of PAF-related disorders including anaphylactic shock, respiratory distress syndrome, acute inflammation, delayed cellular immunity, parturtition, fetal lung maturation, and cellular differentiation.
苯甲酰苯基衍生物2-(3-吡啶基)-3-烷基-4-噻唑烷羧酰胺,2-(3-吡啶基)-噻唑-4-乙酰胺,2-(3-吡啶基)-4-二硫杂环己羧酰胺或2-(3-吡啶基)二硫杂环己-4-基] 尿素是PAF的强效抑制剂,并且在治疗PAF相关疾病中具有用途,包括过敏性休克、呼吸窘迫综合征、急性炎症、细胞免疫延迟、分娩、胎儿肺成熟和细胞分化。